26 related articles for article (PubMed ID: 1300802)
1. [The relationship between the prostaglandin E level in the tumor and the times of the metastasis of primary osteogenic sarcoma].
Bassalyk LS; Kushlinskiĭ NE; Solov'ev IuN; Siniukov PA; Fedenko AN
Vopr Onkol; 1989; 35(11):1301-5. PubMed ID: 2609517
[TBL] [Abstract][Full Text] [Related]
2. [Prostaglandins of series E in morphologic variants of osteogenic sarcoma and evaluation of the degree of therapeutic pathomorphism of the tumor].
Kushlinskiĭ NE; Solov'ev IuN
Arkh Patol; 1995; 57(5):25-30. PubMed ID: 8579490
[TBL] [Abstract][Full Text] [Related]
3. [Polypeptide growth factors and their interrelation with hormones in the blood plasma of patients with primary bone tumors].
Kushlinskiĭ NE; Bassalyk LS; Kuz'mina ZV; Solov'ev IuN; Eremina LA; Amiraslanov AT; Shatskaia VA; Demina DG; Fedenko AN; Siniukov PA
Vopr Onkol; 1991; 37(6):676-83. PubMed ID: 1843144
[TBL] [Abstract][Full Text] [Related]
4. [Experience with and outlook for the use of cisplatin in the combined therapy of osteogenic sarcoma].
Trapeznikov NN; Gorbunova VA; Erëmina LA; Siniukov PA; Kovalevskiĭ EE
Vopr Onkol; 1987; 33(7):65-74. PubMed ID: 3475857
[TBL] [Abstract][Full Text] [Related]
5. [Androgen receptors in the cytosol fraction of a spontaneous osteogenic sarcoma in dogs].
Kushlinskiĭ NE; Mitin VN
Vopr Onkol; 1992; 38(5):571-6. PubMed ID: 1300756
[TBL] [Abstract][Full Text] [Related]
6. [The characteristics of eicosanoid synthesis in osteogenic sarcoma in children at puberty].
Kushlinskiĭ NE; Bassalyk LS; Liakina LT; Solov'ev IuN; Pashkov IuV; Amiraslanov AT; Siniukov PA; Valenteĭ LV; Fedenko AN; Abaev VM
Vopr Onkol; 1992; 38(8):929-35. PubMed ID: 1300802
[TBL] [Abstract][Full Text] [Related]
7. [Pathology of osteogenic sarcoma].
Solov'ev IuN
Arkh Patol; 1982; 44(7):83-6. PubMed ID: 6751299
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of osteogenic sarcoma in children].
Pashkov Iu
Vopr Onkol; 1989; 35(10):1155-60. PubMed ID: 2688308
[No Abstract] [Full Text] [Related]
9. [New strategies in the treatment of osteogenic sarcoma].
Stein M; Kuten A
Harefuah; 1988 Jan; 114(2):65-9. PubMed ID: 3280437
[No Abstract] [Full Text] [Related]
10. [Osteosarcoma: biochemical and endocrinological studies as a basis for its pathogenetic treatments].
Kushlinskiĭ NE; Trapeznikov NN; Solov'ev IuN; Aliev MD; Siniukov PA; Durnov LA
Vestn Ross Akad Med Nauk; 2002; (1):71-4. PubMed ID: 11882979
[TBL] [Abstract][Full Text] [Related]
11. In vivo 31P nuclear magnetic resonance spectroscopy of osteosarcoma.
Mooyaart EL; Kamman RL; Boeve WJ
Cancer Treat Res; 1993; 62():19-24. PubMed ID: 8096733
[No Abstract] [Full Text] [Related]
12. [Hormones and auto-paracrine tumor growth regulators in osteogenic sarcoma].
Kushlinskiĭ NE
Vestn Ross Akad Med Nauk; 1998; (12):54-8. PubMed ID: 9987964
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
